1 man dead, 1 in custody after plasma center shooting, witnesses say shooter warned them
Police were called to the scene about 3 p.m. A man was pronounced dead and another was in custody, officials said.
The Corner1d
SEC concludes investigation into Grifols over Gotham City report, no penalties announced
The Securities and Exchange Commission (American stock market regulator) reportedly concluded its investigation into Grifols ...
Grifols (NASDAQ:GRFS) Raised to Strong-Buy at Berenberg Bank
Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...
New Atlas10d
World-first treatment to prevent long-term eye damage from mustard gas
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to ...
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time ...
ETF Daily News3d
International Assets Investment Management LLC Takes Position in Grifols, S.A. (NASDAQ:GRFS)
International Assets Investment Management LLC acquired a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC.
High Growth Tech Stocks to Watch in November 2024
As global markets react to rising U.S. Treasury yields and a tempered outlook for Federal Reserve rate cuts, small-cap stocks have felt the pressure more acutely than their large-cap counterparts. In ...
Investing8d
Grifols' pediatric bleeding control solution gets FDA nod
BARCELONA - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), the global healthcare company known for its plasma-derived medicines, has received U.S. FDA approval for its Fibrin Sealant (FS) for use in ...